Omacetaxine for Consolidation and Maintenance

Clinical trial NCT01873495 · TERMINATED

Trial details

NCT number: NCT01873495
Sponsor: Emory University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia (AML)

Start date: 2013-05-01
Primary completion: 2018-07-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.